PL2356227T3 - CAPSULATION OF Pancreas CELLS ORIGINATING FROM HUMAN PLURIPOTENTIAL STEM CELLS - Google Patents

CAPSULATION OF Pancreas CELLS ORIGINATING FROM HUMAN PLURIPOTENTIAL STEM CELLS

Info

Publication number
PL2356227T3
PL2356227T3 PL09826863T PL09826863T PL2356227T3 PL 2356227 T3 PL2356227 T3 PL 2356227T3 PL 09826863 T PL09826863 T PL 09826863T PL 09826863 T PL09826863 T PL 09826863T PL 2356227 T3 PL2356227 T3 PL 2356227T3
Authority
PL
Poland
Prior art keywords
capsulation
cells
pancreas
originating
pluripotential stem
Prior art date
Application number
PL09826863T
Other languages
Polish (pl)
Inventor
Laura Martinson
Chad Green
Evert Kroon
Alan Agulnick
Olivia Kelly
Emmanuel E. Baetge
Original Assignee
Viacyte, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viacyte, Inc. filed Critical Viacyte, Inc.
Publication of PL2356227T3 publication Critical patent/PL2356227T3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • A01N1/125—Freeze protecting agents, e.g. cryoprotectants or osmolarity regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/022—Artificial gland structures using bioreactors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/39—Pancreas; Islets of Langerhans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0676—Pancreatic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0676—Pancreatic cells
    • C12N5/0678—Stem cells; Progenitor cells; Precursor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/126—Immunoprotecting barriers, e.g. jackets, diffusion chambers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/62—Encapsulated active agents, e.g. emulsified droplets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/64—Animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/07—Proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/04—General characteristics of the apparatus implanted
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/117—Keratinocyte growth factors (KGF-1, i.e. FGF-7; KGF-2, i.e. FGF-12)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/119—Other fibroblast growth factors, e.g. FGF-4, FGF-8, FGF-10
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/16—Activin; Inhibin; Mullerian inhibiting substance
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/19—Growth and differentiation factors [GDF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/385—Hormones with nuclear receptors of the family of the retinoic acid recptor, e.g. RAR, RXR; Peroxisome proliferator-activated receptor [PPAR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/41—Hedgehog proteins; Cyclopamine (inhibitor)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/415—Wnt; Frizzeled
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Cell Biology (AREA)
  • Dermatology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Diabetes (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Developmental Biology & Embryology (AREA)
  • Microbiology (AREA)
  • Anesthesiology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Botany (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
PL09826863T 2008-11-14 2009-11-13 CAPSULATION OF Pancreas CELLS ORIGINATING FROM HUMAN PLURIPOTENTIAL STEM CELLS PL2356227T3 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US11485708P 2008-11-14 2008-11-14
US12108608P 2008-12-09 2008-12-09
EP09826863.4A EP2356227B1 (en) 2008-11-14 2009-11-13 Encapsulation of pancreatic cells derived from human pluripotent stem cells
PCT/US2009/064459 WO2010057039A2 (en) 2008-11-14 2009-11-13 Encapsulation of pancreatic cells derived from human pluripotent stem cells

Publications (1)

Publication Number Publication Date
PL2356227T3 true PL2356227T3 (en) 2018-07-31

Family

ID=42170745

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09826863T PL2356227T3 (en) 2008-11-14 2009-11-13 CAPSULATION OF Pancreas CELLS ORIGINATING FROM HUMAN PLURIPOTENTIAL STEM CELLS

Country Status (9)

Country Link
US (9) US8278106B2 (en)
EP (3) EP4176888A1 (en)
JP (6) JP2012508584A (en)
CN (2) CN105349517B (en)
AU (1) AU2009313870B2 (en)
CA (1) CA2743641C (en)
ES (2) ES2932850T3 (en)
PL (1) PL2356227T3 (en)
WO (1) WO2010057039A2 (en)

Families Citing this family (175)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003014313A2 (en) * 2001-08-06 2003-02-20 Bresagen, Ltd. Alternative compositions and methods for the culture of stem cells
US9080145B2 (en) 2007-07-01 2015-07-14 Lifescan Corporation Single pluripotent stem cell culture
CA3114827C (en) 2007-07-31 2023-09-05 Lifescan, Inc. Differentiation of human embryonic stem cells to pancreatic endocrine
EP2229434B1 (en) 2007-11-27 2011-09-07 Lifescan, Inc. Differentiation of human embryonic stem cells
KR101731474B1 (en) 2008-02-21 2017-05-11 얀센 바이오테크 인코포레이티드 Methods, surface modified plates and compositions for cell attachment, cultivation and detachment
GB2460842B (en) * 2008-06-10 2011-02-16 Cryogenetics As Packaging for biological material
PL2310492T3 (en) 2008-06-30 2015-12-31 Janssen Biotech Inc Differentiation of pluripotent stem cells
MX349178B (en) 2008-10-31 2017-07-17 Centocor Ortho Biotech Inc Differentiation of human embryonic stem cells to the pancreatic endocrine lineage.
PL2346988T3 (en) 2008-10-31 2017-10-31 Janssen Biotech Inc Differentiation of human embryonic stem cells to the pancreatic endocrine lineage
US8008075B2 (en) 2008-11-04 2011-08-30 Viacyte, Inc. Stem cell aggregate suspension compositions and methods of differentiation thereof
US8895300B2 (en) 2008-11-04 2014-11-25 Viacyte, Inc. Scalable primate pluripotent stem cell aggregate suspension culture and differentiation thereof
AU2009313870B2 (en) 2008-11-14 2013-07-11 Viacyte, Inc. Encapsulation of pancreatic cells derived from human pluripotent stem cells
ES2584053T3 (en) 2008-11-20 2016-09-23 Janssen Biotech, Inc. Methods and compositions for cell binding and culture in flat substrates
ES2642070T3 (en) 2008-11-20 2017-11-15 Janssen Biotech, Inc. Cultivation of pluripotent stem cells in microcarriers
US9109245B2 (en) 2009-04-22 2015-08-18 Viacyte, Inc. Cell compositions derived from dedifferentiated reprogrammed cells
KR102058901B1 (en) * 2009-07-20 2019-12-24 얀센 바이오테크 인코포레이티드 Differentiation of human embryonic stem cells
EA025142B1 (en) 2009-08-28 2016-11-30 Сернова Корпорэйнш Method and device for cellular transplantation
DK2498796T3 (en) 2009-11-09 2018-03-05 Aal Scient Inc HEART DISEASE TREATMENT
SG181687A1 (en) 2009-12-23 2012-07-30 Centocor Ortho Biotech Inc Differentiation of human embryonic stem cells
US8455242B2 (en) 2010-02-22 2013-06-04 Hyclone Laboratories, Inc. Mixing system with condenser
EP2542667A4 (en) 2010-03-01 2013-07-31 Janssen Biotech Inc Methods for purifying cells derived from pluripotent stem cells
RU2663339C1 (en) 2010-05-12 2018-08-03 Янссен Байотек, Инк. Differentiation of human embryo stem cells
SG187655A1 (en) 2010-08-09 2013-03-28 Takeda Pharmaceutical Method of producing pancreatic hormone-producing cells
AU2015213422A1 (en) * 2010-08-12 2015-09-10 Janssen Biotech, Inc. Treatment of diabetes with pancreatic endocrine precursor cells
US20120039955A1 (en) * 2010-08-12 2012-02-16 Janssen Biotech, Inc. Treatment of Diabetes with Pancreatic Endocrine Precursor Cells
US9475709B2 (en) 2010-08-25 2016-10-25 Lockheed Martin Corporation Perforated graphene deionization or desalination
CN103221536B (en) 2010-08-31 2016-08-31 詹森生物科技公司 The differentiation of human embryo stem cell
EP2611907B1 (en) 2010-08-31 2016-05-04 Janssen Biotech, Inc. Differentiation of pluripotent stem cells
ES2658146T3 (en) 2010-08-31 2018-03-08 Janssen Biotech, Inc. Differentiation of human embryonic stem cells
CA2812707C (en) * 2010-09-27 2020-02-18 Gloriana Therapeutics Sarl Implantable cell device with supportive and radial diffusive scaffolding
MX2010013135A (en) * 2010-11-30 2012-05-31 Val De Bio S De R L De C V Improved device and process for facilitating the transplant of biological material.
US9433557B2 (en) 2011-02-21 2016-09-06 Viacyte, Inc. Loading system for an encapsulation device
WO2012175633A1 (en) 2011-06-21 2012-12-27 Novo Nordisk A/S Efficient induction of definitive endoderm from pluripotent stem cells
CN102550542B (en) * 2011-08-09 2014-06-25 臻景生物技术（上海）有限公司 Establishment for serum-free freezing medium and adipose-derived stem cell library of adipose-derived stem cells
US20140242038A1 (en) * 2011-10-11 2014-08-28 The Trustees Of Columbia University In The City Of New York Method for generating beta cells
USD726307S1 (en) * 2011-12-12 2015-04-07 Viacyte Inc. Cell encapsulation device
USD728095S1 (en) * 2011-12-12 2015-04-28 Viacyte, Inc. Cell encapsulation device
USD726306S1 (en) * 2011-12-12 2015-04-07 Viacyte, Inc. Cell encapsulation device
KR102203056B1 (en) 2011-12-22 2021-01-14 얀센 바이오테크 인코포레이티드 Differentiation of human embryonic stem cells into single hormonal insulin positive cells
HK1206058A1 (en) 2012-03-07 2015-12-31 Janssen Biotech, Inc. Defined media for expansion and maintenance of pluripotent stem cells
US10376845B2 (en) 2016-04-14 2019-08-13 Lockheed Martin Corporation Membranes with tunable selectivity
US9834809B2 (en) 2014-02-28 2017-12-05 Lockheed Martin Corporation Syringe for obtaining nano-sized materials for selective assays and related methods of use
US10213746B2 (en) 2016-04-14 2019-02-26 Lockheed Martin Corporation Selective interfacial mitigation of graphene defects
US9610546B2 (en) 2014-03-12 2017-04-04 Lockheed Martin Corporation Separation membranes formed from perforated graphene and methods for use thereof
US9744617B2 (en) 2014-01-31 2017-08-29 Lockheed Martin Corporation Methods for perforating multi-layer graphene through ion bombardment
US10653824B2 (en) 2012-05-25 2020-05-19 Lockheed Martin Corporation Two-dimensional materials and uses thereof
USD734847S1 (en) * 2012-05-31 2015-07-21 Viacyte, Inc. Cell encapsulation device
AU2013271581B2 (en) 2012-06-08 2018-08-09 Janssen Biotech, Inc. Differentiation of human embryonic stem cells into pancreatic endocrine cells
US20150320836A1 (en) * 2012-07-06 2015-11-12 The Regents Of The University Of California Cryopreservation of cells inside a macro-encapsulation device
EP2893000B1 (en) 2012-09-03 2019-04-10 Novo Nordisk A/S Generation of pancreatic endoderm from pluripotent stem cells using small molecules
AU2013248265B2 (en) 2012-11-08 2018-11-01 Viacyte, Inc. Scalable primate pluripotent stem cell aggregate suspension culture and differentiation thereof
JP6557147B2 (en) 2012-12-31 2019-08-07 ヤンセン バイオテツク，インコーポレーテツド Differentiation of human embryonic stem cells into pancreatic endocrine cells using HB9 modulators
BR112015015770A2 (en) 2012-12-31 2017-07-11 Janssen Biotech Inc Human embryonic stem cell culture at air-liquid interface for differentiation in endocrine pancreatic cells
RU2687379C2 (en) 2012-12-31 2019-05-13 Янссен Байотек, Инк. Suspending and clustering of human pluripotent cells with the purpose of their differentiation in pancreatic endocrine cells
US10370644B2 (en) 2012-12-31 2019-08-06 Janssen Biotech, Inc. Method for making human pluripotent suspension cultures and cells derived therefrom
CA3212301A1 (en) * 2013-02-06 2014-08-14 Viacyte, Inc. Cell compositions derived from dedifferentiated reprogrammed cells
US20150368616A1 (en) * 2013-02-14 2015-12-24 The Cleveland Clinic Foundation Methods for induction of cell fates from pluripotent cells
JP6234485B2 (en) 2013-03-07 2017-11-22 ヴィアサイト インコーポレイテッド 3D large capacity cell encapsulation device assembly
USD720469S1 (en) 2013-03-07 2014-12-30 Viacyte, Inc. Cell encapsulation device
WO2014138671A2 (en) * 2013-03-08 2014-09-12 Viacyte, Inc. Cryopreservation, hibernation and room temperature storage of encapulated pancreatic endoderm cell aggregates
WO2014164621A1 (en) 2013-03-12 2014-10-09 Lockheed Martin Corporation Method for forming filter with uniform aperture size
US8859286B2 (en) * 2013-03-14 2014-10-14 Viacyte, Inc. In vitro differentiation of pluripotent stem cells to pancreatic endoderm cells (PEC) and endocrine cells
EP2988699B1 (en) 2013-04-24 2020-05-27 Société des Produits Nestlé S.A. Encapsulation device
SG11201510177WA (en) 2013-06-11 2016-01-28 Harvard College SC-β CELLS AND COMPOSITIONS AND METHODS FOR GENERATING THE SAME
US9572918B2 (en) 2013-06-21 2017-02-21 Lockheed Martin Corporation Graphene-based filter for isolating a substance from blood
KR102250588B1 (en) * 2013-07-02 2021-05-12 오스트리아노바 싱가포르 피티이 리미티드 A method of freeze-drying encapsulated cells, freeze-dried encapsulated cells, compositions containing freeze-dried encapsulated cells and uses of such cells and compositions
CN105792775B (en) 2013-09-24 2019-02-19 吉纳生命科学公司 System for gas treatment of cellular implants
SG11201606287VA (en) 2014-01-31 2016-08-30 Lockheed Corp Processes for forming composite structures with a two-dimensional material using a porous, non-sacrificial supporting layer
WO2015116946A1 (en) 2014-01-31 2015-08-06 Lockheed Martin Corporation Perforating two-dimensional materials using broad ion field
USD718471S1 (en) * 2014-03-07 2014-11-25 Viacyte, Inc. 3-dimensional large capacity cell encapsulation device
USD718472S1 (en) * 2014-03-07 2014-11-25 Viacyte, Inc. 3-dimensional large capacity cell encapsulation device
USD718468S1 (en) * 2014-03-07 2014-11-25 Viacyte, Inc. 3-dimensional large capacity cell encapsulation device
USD718467S1 (en) * 2014-03-07 2014-11-25 Viacyte, Inc. 3-dimensional large capacity cell encapsulation device
USD718469S1 (en) * 2014-03-07 2014-11-25 Viacyte, Inc. 3-dimensional large capacity cell encapsulation device
USD718466S1 (en) * 2014-03-07 2014-11-25 Viacyte, Inc. 3-Dimensional large capacity cell encapsulation device
USD718470S1 (en) * 2014-03-07 2014-11-25 Viacyte, Inc. 3-dimensional large capacity cell encapsulation device
USD714956S1 (en) * 2014-03-07 2014-10-07 Viacyte, Inc. 3-dimensional large capacity cell encapsulation device
SG11201607584PA (en) * 2014-03-12 2016-10-28 Lockheed Corp In vivo and in vitro use of graphene
CN106232205A (en) 2014-03-12 2016-12-14 洛克希德马丁公司 The separation film formed by porose Graphene
JP6585615B2 (en) 2014-03-21 2019-10-02 ライフ テクノロジーズ コーポレイション Condenser system for fluid treatment system
BR122022000294B1 (en) 2014-03-21 2022-08-16 Life Technologies Corporation FILTERING ASSEMBLY AND METHOD TO FILTER A GAS
US9950151B2 (en) * 2014-03-27 2018-04-24 Beta-O2 Technologies Ltd. Implantable medical devices
USD760399S1 (en) * 2014-04-16 2016-06-28 Viacyte, Inc. Case for an encapsulation device
WO2015160348A1 (en) 2014-04-16 2015-10-22 Viacyte, Inc. Tools and instruments for use with implantable encsapsulation devices
US11051900B2 (en) * 2014-04-16 2021-07-06 Viacyte, Inc. Tools and instruments for use with implantable encapsulation devices
WO2015175776A1 (en) * 2014-05-14 2015-11-19 NuTech Medical, Inc. Placental membrane preparations and methods of making and using same for regenerating cartilage and spinal intervertebral discs
US10006006B2 (en) 2014-05-16 2018-06-26 Janssen Biotech, Inc. Use of small molecules to enhance MAFA expression in pancreatic endocrine cells
CN106536718B (en) * 2014-05-21 2021-04-27 国立大学法人京都大学 Method for producing pancreatic bud cells and therapeutic agent for pancreatic diseases containing pancreatic bud cells
WO2015191547A1 (en) 2014-06-09 2015-12-17 Cornell University Implantable therapeutic delivery system and methods thereof
MX2017002738A (en) 2014-09-02 2017-08-02 Lockheed Corp Hemodialysis and hemofiltration membranes based upon a two-dimensional membrane material and methods employing same.
CN107614678B (en) * 2014-12-18 2021-04-30 哈佛学院校长同事会 Method for producing stem cell-derived beta cells and method for using same
WO2016100898A1 (en) 2014-12-18 2016-06-23 President And Fellows Of Harvard College Serum-free in vitro directed differentiation protocol for generating stem cell-derived b cells and uses thereof
WO2016100909A1 (en) 2014-12-18 2016-06-23 President And Fellows Of Harvard College METHODS FOR GENERATING STEM CELL-DERIVED β CELLS AND USES THEREOF
AU2016235152B2 (en) * 2015-03-23 2020-09-03 The Regents Of The University Of California Thin film cell encapsulation devices
CA2983764A1 (en) 2015-04-24 2016-10-27 University Of Copenhagen Isolation of bona fide pancreatic progenitor cells
WO2017023376A1 (en) 2015-08-05 2017-02-09 Lockheed Martin Corporation Perforatable sheets of graphene-based material
JP2018530499A (en) 2015-08-06 2018-10-18 ロッキード・マーチン・コーポレーション Nanoparticle modification and perforation of graphene
WO2017049008A1 (en) * 2015-09-16 2017-03-23 Lockheed Martin Corporation Methods for in vivo and in vitro use of graphene and other two-dimensional materials
EP3167911A1 (en) * 2015-11-10 2017-05-17 Oniris Si-hpmc-encapsulated insulin-producing cells for the treatment of type 1 diabetes
WO2017116910A1 (en) * 2015-12-29 2017-07-06 Life Technologies Corporation Flexible bioprocessing container with partial dividing partition
EP3402330B1 (en) * 2016-01-12 2021-12-29 StemoniX Inc. Cell medium formulation for cell stabilization
US11534466B2 (en) 2016-03-09 2022-12-27 Aal Scientifics, Inc. Pancreatic stem cells and uses thereof
WO2017165850A1 (en) * 2016-03-25 2017-09-28 Lockheed Martin Corporation Methods for in vivo and in vitro use of graphene and other two-dimensional materials
WO2017180134A1 (en) 2016-04-14 2017-10-19 Lockheed Martin Corporation Methods for in vivo and in vitro use of graphene and other two-dimensional materials
KR20190018410A (en) 2016-04-14 2019-02-22 록히드 마틴 코포레이션 Two-dimensional membrane structures with flow passages
EP3442739A4 (en) 2016-04-14 2020-03-04 Lockheed Martin Corporation Method for treating graphene sheets for large-scale transfer using free-float method
DK3443073T3 (en) * 2016-04-14 2024-09-02 Janssen Biotech Inc DIFFERENTIATION OF PLURIPOTENT STEM CELLS TO INTESTINAL MEDIUM ENDOWER CELLS
KR20180133430A (en) 2016-04-14 2018-12-14 록히드 마틴 코포레이션 Method for in situ monitoring and control of defect formation or healing
EP3484997A4 (en) 2016-07-12 2020-07-29 California Institute of Technology SUBSTRATES FOR HIGH-DENSITY CELL GROWTH AND METABOLITE EXCHANGE
EP3534793B1 (en) * 2016-11-03 2025-12-31 Arizona Board of Regents on behalf of the University of Arizona METHODS, SYSTEMS AND IMPLANTABLE DEVICES FOR IMPROVED BLOOD SUGAR LEVEL REGULATION
KR102460406B1 (en) 2016-11-03 2022-10-31 아리조나 보드 오브 리전츠 온 비해프 오브 더 유니버시티 오브 아리조나 Layered Tissue Encapsulation Device Systems with or Without Oxygen Delivery
KR20190106996A (en) 2016-11-03 2019-09-18 아리조나 보드 오브 리전츠 온 비해프 오브 더 유니버시티 오브 아리조나 Encapsulation system with oxygen sensor with or without external oxygen transfer
KR102649881B1 (en) * 2016-11-03 2024-03-20 아리조나 보드 오브 리전츠 온 비해프 오브 더 유니버시티 오브 아리조나 Methods and systems for real-time assessment of cells in encapsulation devices pre-and post-transplantation
US10849731B2 (en) * 2016-11-08 2020-12-01 W. L. Gore & Associates, Inc. Cell encapsulation devices containing structural spacers
US11052230B2 (en) * 2016-11-08 2021-07-06 W. L. Gore & Associates, Inc. Implantable encapsulation devices
USD824042S1 (en) 2016-11-10 2018-07-24 Viacyte, Inc. Perforated cell encapsulation device
DK3537986T3 (en) 2016-11-10 2025-07-21 Viacyte Inc PDX1 PANCREATIC ENDODERMAL CELLS IN CELL DELIVERY DEVICE
JP7044268B2 (en) 2016-11-15 2022-03-30 ガイナー ライフ サイエンシズ，インク． Self-regulating electrolytic gas generator and implant system with it
MX2019005676A (en) 2016-11-15 2019-09-10 Giner Life Sciences Inc Percutaneous gas diffusion device suitable for use with a subcutaneous implant.
CN108148808B (en) * 2016-12-05 2020-12-11 同济大学 Induction medium for the induction of neural precursor cells
EP3591040A4 (en) * 2017-03-03 2020-11-11 Kyoto University METHOD FOR PRODUCING PANCREATIC ANALYZER CELLS
US12016327B2 (en) * 2017-03-20 2024-06-25 Boston Scientific Medical Device Limited Cell encapsulation device
JP7199632B2 (en) 2017-05-04 2023-01-06 ガイナー，インク． Robust Implantable Gas Delivery Device and Methods, Systems and Devices Containing The Same
EP3409239A1 (en) 2017-05-29 2018-12-05 University College Dublin, National University of Ireland, Dublin An implantable active agent encapsulating device
CN111565707A (en) 2017-06-14 2020-08-21 森玛治疗公司 Devices and methods for delivering therapeutics
WO2018230588A1 (en) 2017-06-14 2018-12-20 武田薬品工業株式会社 Cell-sealing device
KR102001120B1 (en) 2017-06-29 2019-07-16 서울대학교산학협력단 Complex of nanofiber and hydrogel and a scaffold for tissue regeneration
US10391156B2 (en) 2017-07-12 2019-08-27 Viacyte, Inc. University donor cells and related methods
EP3677289A4 (en) 2017-08-30 2020-08-26 FUJIFILM Corporation ANGIOGUE AGENT AND MANUFACTURING METHOD FOR IT
WO2019044990A1 (en) 2017-08-30 2019-03-07 富士フイルム株式会社 Cell transplantation device and method for manufacturing same
AU2018330499B2 (en) * 2017-09-11 2025-01-30 Novo Nordisk A/S Enrichment of NKX6.1 and C-peptide co-expressing cells derived in vitro from stem cells
AU2018342581B2 (en) 2017-09-29 2024-06-20 Vertex Pharmaceuticals Incorporated Cell housing device
CA2983845C (en) 2017-10-26 2024-01-30 University Of Copenhagen Generation of glucose-responsive beta cells
KR20250048146A (en) * 2017-11-15 2025-04-07 셈마 테라퓨틱스, 인크. Islet cell manufacturing compositions and methods of use
JP2019097442A (en) 2017-11-30 2019-06-24 株式会社日立製作所 Immunoisolation device
JP6417023B2 (en) * 2017-12-20 2018-10-31 ネステク ソシエテ アノニム Encapsulation device
CN108543116B (en) * 2018-05-02 2021-04-27 深圳市华异生物科技有限责任公司 Sodium alginate and gelatin composite hydrogel 3D islet scaffold and preparation method thereof
CA3100192C (en) 2018-05-17 2023-03-14 Giner Life Sciences, Inc. Electrolytic gas generator with combined lead and gas port terminals
US20210292708A1 (en) * 2018-08-03 2021-09-23 Kyoto University Cell production method
WO2020033879A1 (en) 2018-08-10 2020-02-13 Semma Therapeutics, Inc. Stem cell derived islet differentiation
US11963862B2 (en) 2018-08-22 2024-04-23 Boston Scientific Scimed, Inc. Cell encapsulation device including a porous tube
US12408661B2 (en) * 2018-08-30 2025-09-09 The Curators Of The University Of Missouri Efficient cryopreservation device preventing the direct contact between samples and extracellular ice
US12378572B2 (en) 2018-09-07 2025-08-05 Crispr Therapeutics Ag Universal donor cells
EP3856078A4 (en) * 2018-09-24 2022-11-02 Procyon Technologies LLC METHODS AND SYSTEMS FOR IMPLANTABLE MEDICAL DEVICES AND VASCULARIZATION MEMBRANES
EP3856077B1 (en) * 2018-09-26 2024-11-06 W. L. Gore & Associates, Inc. Cell encapsulation devices with controlled cell bed thickness
UY38389A (en) 2018-09-27 2020-04-30 Sigilon Therapeutics Inc IMPLANTABLE DEVICES FOR CELLULAR THERAPY AND RELATED METHODS
KR20210077698A (en) * 2018-10-15 2021-06-25 사이니티 가부시키가이샤 Method for producing stem/progenitor cells from endoderm tissue or organ-derived cells using low molecular weight compounds
CN109289090A (en) * 2018-10-31 2019-02-01 陈津 A kind of pancreatic islets transplantation microenvironment and its construction method
WO2020138028A1 (en) * 2018-12-25 2020-07-02 富士フイルム株式会社 Cell transplant kit, method for manufacturing bag-like structure, and therapeutic agent for diabetes
JP6970245B2 (en) * 2019-02-25 2021-11-24 ヴィアサイト インコーポレイテッド Tools and instruments for use with implantable encapsulation devices
JP7267377B2 (en) * 2019-02-25 2023-05-01 ヴィアサイト インコーポレイテッド Tools and instruments for use with implantable containment devices
JP2022527352A (en) * 2019-04-03 2022-06-01 バーテックス ファーマシューティカルズ インコーポレイテッド Multi-chamber macro encapsulation device
WO2020243665A1 (en) 2019-05-31 2020-12-03 W. L. Gore & Associates, Inc. A biocompatible membrane composite
AU2020282355B2 (en) 2019-05-31 2023-11-02 Viacyte, Inc. A biocompatible membrane composite
CN114401752B (en) 2019-05-31 2023-04-04 W.L.戈尔及同仁股份有限公司 Cell encapsulation device with controlled oxygen diffusion distance
WO2020243666A1 (en) 2019-05-31 2020-12-03 W. L. Gore & Associates, Inc. A biocompatible membrane composite
US11104918B2 (en) 2019-09-05 2021-08-31 Crispr Therapeutics Ag Universal donor cells
KR20220058579A (en) 2019-09-05 2022-05-09 크리스퍼 테라퓨틱스 아게 universal donor cells
US20210093435A1 (en) * 2019-09-27 2021-04-01 Isla Technologies, Inc. Bioartificial pancreas
WO2022047543A1 (en) * 2020-09-04 2022-03-10 Captix Biomedical Pty Ltd "bone implant"
KR20230117119A (en) * 2020-10-30 2023-08-07 아리조나 보드 오브 리전츠 온 비해프 오브 더 유니버시티 오브 아리조나 Methods and systems for encapsulation devices for containing cells and materials
CN112544613B (en) * 2020-12-25 2022-08-16 武汉睿健医药科技有限公司 Pluripotent stem cell cryopreservation liquid, application thereof and cryopreservation method
KR20230146007A (en) 2020-12-31 2023-10-18 크리스퍼 테라퓨틱스 아게 universal donor cells
JP2024515772A (en) * 2021-04-27 2024-04-10 サノフイ Manufacturing of therapeutic devices and systems containing a plurality of cells
US20240342343A1 (en) * 2021-08-10 2024-10-17 Universiteit Maastricht Open type implantable cell delivery device
WO2023164171A2 (en) 2022-02-25 2023-08-31 Viacyte, Inc. Multilayer implantable cell encapsulation devices and methods thereof
US20250283046A1 (en) 2022-04-21 2025-09-11 Evotec International Gmbh New Cell Populations and Means and Methods for their Differentiation and Preservation
WO2024039773A1 (en) 2022-08-19 2024-02-22 Dimension Inx Corp Biointegrative implantable cell encapsulation device and system
JP2025532936A (en) 2022-09-30 2025-10-03 ダブリュ．エル．ゴア アンド アソシエイツ，インコーポレイティド Implantable membrane structures and encapsulated devices incorporating same
EP4602155A1 (en) 2022-10-11 2025-08-20 Sigilon Therapeutics, Inc. Engineered cells and implantable elements for treatment of disease
JP2025534667A (en) 2022-10-11 2025-10-17 シギロン セラピューティクス， インコーポレイテッド Engineered cells and implantable elements for disease treatment
WO2025088022A1 (en) 2023-10-24 2025-05-01 Technische Universität Dresden, Körperschaft des öffentlichen Rechts Method for generating homogenous, size-defined pseudo-islets of porcine origin by rho/rock pathway inhibition
JP7451818B1 (en) 2023-11-10 2024-03-18 洋之 高尾 Diffusion Chamber type artificial islet device
WO2025226588A1 (en) * 2024-04-22 2025-10-30 Wake Forest University Health Sciences Artificial implants that promote neovascularization
WO2026039350A1 (en) 2024-08-13 2026-02-19 Isp Investments Llc A lactam moiety based cryoprotectant, compositions thereof and a method of cryopreservation of biological materials

Family Cites Families (163)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2500388A (en) 1948-07-21 1950-03-14 Minnesota Mining & Mfg Fluorocarbon ethers
US2594272A (en) 1948-09-10 1952-04-29 Minnesota Mining & Mfg Cyclic fluoroalkylene oxide compounds
US2519983A (en) 1948-11-29 1950-08-22 Minnesota Mining & Mfg Electrochemical process of making fluorine-containing carbon compounds
US2616927A (en) 1950-05-12 1952-11-04 Minnesota Mining & Mfg Fluorocarbon tertiary amines
US4298002A (en) * 1979-09-10 1981-11-03 National Patent Development Corporation Porous hydrophilic materials, chambers therefrom, and devices comprising such chambers and biologically active tissue and methods of preparation
US4542104A (en) * 1983-04-06 1985-09-17 The Board Of Trustees Of The Leland Stanford Jr. Univ. Phycobiliprotein fluorescent conjugates
US4723953A (en) * 1985-01-07 1988-02-09 Rocky Mountain Medical Corporation Absorbent pad
US4788339A (en) 1985-09-06 1988-11-29 Minnesota Mining And Manufacturing Company Perfluoroaminoethers
US5026365A (en) * 1987-04-29 1991-06-25 The University Of Massachusetts Method and apparatus for therapeutically treating immunological disorders and disease states
US5106627A (en) * 1987-11-17 1992-04-21 Brown University Research Foundation Neurological therapy devices
US5182111A (en) 1987-11-17 1993-01-26 Boston University Research Foundation In vivo delivery of active factors by co-cultured cell implants
US5418154A (en) 1987-11-17 1995-05-23 Brown University Research Foundation Method of preparing elongated seamless capsules containing biological material
US5283187A (en) 1987-11-17 1994-02-01 Brown University Research Foundation Cell culture-containing tubular capsule produced by co-extrusion
US5158881A (en) * 1987-11-17 1992-10-27 Brown University Research Foundation Method and system for encapsulating cells in a tubular extrudate in separate cell compartments
US5011494A (en) * 1988-09-16 1991-04-30 Clemson University Soft tissue implant with micron-scale surface texture to optimize anchorage
US5219361A (en) 1988-09-16 1993-06-15 Clemson University Soft tissue implant with micron-scale surface texture to optimize anchorage
CA1335181C (en) 1988-10-11 1995-04-11 R. Alan Hardwick System for selective cell separation from cell concentrate
ES2067018T3 (en) 1988-12-28 1995-03-16 Stefan Miltenyi PROCEDURE AND MATERIALS FOR THE SEPARATION IN HIGH MAGNETIC GRADIENT OF BIOLOGICAL MATERIALS.
US5002661A (en) 1989-08-25 1991-03-26 W. R. Grace & Co.-Conn. Artificial pancreatic perfusion device
US5116493A (en) 1989-08-25 1992-05-26 W. R. Grace & Co.-Conn. Artificial pancreatic perfusion device with reseedable matrix
US5100392A (en) * 1989-12-08 1992-03-31 Biosynthesis, Inc. Implantable device for administration of drugs or other liquid solutions
US5272257A (en) * 1990-05-21 1993-12-21 Coulter Corporation Method of preferential labelling of a phycobiliprotein with an amine-reactive dye for use in a multiple color assay and product for such use
US5171846A (en) * 1990-05-21 1992-12-15 Coulter Corporation Method of preferential labelling of a phycobiliprotein with a second dye for use in a multiple color assay and product for such use
US5240640A (en) * 1990-06-04 1993-08-31 Coulter Corporation In situ use of gelatin or an aminodextran in the preparation of uniform ferrite particles
US5529914A (en) 1990-10-15 1996-06-25 The Board Of Regents The Univeristy Of Texas System Gels for encapsulation of biological materials
US5713888A (en) * 1990-10-31 1998-02-03 Baxter International, Inc. Tissue implant systems
US5314471A (en) * 1991-07-24 1994-05-24 Baxter International Inc. Tissue inplant systems and methods for sustaining viable high cell densities within a host
US5344454A (en) * 1991-07-24 1994-09-06 Baxter International Inc. Closed porous chambers for implanting tissue in a host
US5466609A (en) * 1990-10-31 1995-11-14 Coulter Corporation Biodegradable gelatin-aminodextran particle coatings of and processes for making same
EP0507933B1 (en) 1990-10-31 1996-05-22 Baxter International Inc. Close vascularization implant material
US5545223A (en) 1990-10-31 1996-08-13 Baxter International, Inc. Ported tissue implant systems and methods of using same
US5639620A (en) * 1990-10-31 1997-06-17 Coulter Corporation Polymeric particles having a biodegradable gelatin or aminodextran coating and process for making same
CA2111858A1 (en) 1991-07-15 1993-02-04 James S. Crowe Production of antibodies
US5453278A (en) 1991-07-24 1995-09-26 Baxter International Inc. Laminated barriers for tissue implants
US6773458B1 (en) 1991-07-24 2004-08-10 Baxter International Inc. Angiogenic tissue implant systems and methods
JPH06502577A (en) 1991-07-30 1994-03-24 バクスター、インターナショナル、インコーポレイテッド perforated implant
JPH0613739Y2 (en) * 1991-09-26 1994-04-13 富士システムズ株式会社 Capsule for artificial organ and artificial organ
US5248772A (en) * 1992-01-29 1993-09-28 Coulter Corporation Formation of colloidal metal dispersions using aminodextrans as reductants and protective agents
US6165993A (en) 1992-03-23 2000-12-26 University Of Massachusetts Medical Center DNA vaccines against rotavirus infections
WO1993021902A1 (en) * 1992-04-24 1993-11-11 Somatix Therapy Corporation Biocompatible, therapeutic, implantable device
US5690926A (en) * 1992-10-08 1997-11-25 Vanderbilt University Pluripotential embryonic cells and methods of making same
US7153684B1 (en) 1992-10-08 2006-12-26 Vanderbilt University Pluripotential embryonic stem cells and methods of making same
US5453357A (en) * 1992-10-08 1995-09-26 Vanderbilt University Pluripotential embryonic stem cells and methods of making same
US5262055A (en) 1992-10-19 1993-11-16 The University Of Utah Implantable and refillable biohybrid artificial pancreas
US5593972A (en) 1993-01-26 1997-01-14 The Wistar Institute Genetic immunization
US5523226A (en) 1993-05-14 1996-06-04 Biotechnology Research And Development Corp. Transgenic swine compositions and methods
CA2164646A1 (en) * 1993-06-11 1994-12-22 Wade E. Bolton Anti-cd3 antibody-aminodextran conjugates for induction of t-cell activation and proliferation
AU688776B2 (en) * 1993-06-23 1998-03-19 Brown University Research Foundation Method and apparatus for sealing implantable, membrane encapsulation devices
WO1995008355A1 (en) 1993-09-24 1995-03-30 Baxter International Inc. Methods for enhancing vascularization of implant devices
US6015671A (en) 1995-06-07 2000-01-18 Indiana University Foundation Myocardial grafts and cellular compositions
US5421923A (en) * 1993-12-03 1995-06-06 Baxter International, Inc. Ultrasonic welding horn with sonics dampening insert
US5549675A (en) * 1994-01-11 1996-08-27 Baxter International, Inc. Method for implanting tissue in a host
US6156305A (en) 1994-07-08 2000-12-05 Baxter International Inc. Implanted tumor cells for the prevention and treatment of cancer
US5989833A (en) * 1994-09-20 1999-11-23 Institut National De La Sante Et De La Recherche Medicale (Inserm) Methods for detection of molecules with affinity for MPL polypeptides
US5807406A (en) * 1994-10-07 1998-09-15 Baxter International Inc. Porous microfabricated polymer membrane structures
US5874301A (en) 1994-11-21 1999-02-23 National Jewish Center For Immunology And Respiratory Medicine Embryonic cell populations and methods to isolate such populations
US5843780A (en) * 1995-01-20 1998-12-01 Wisconsin Alumni Research Foundation Primate embryonic stem cells
US5705059A (en) 1995-02-27 1998-01-06 Miltenyi; Stefan Magnetic separation apparatus
WO1996032076A1 (en) * 1995-04-11 1996-10-17 Baxter Internatonal Inc. Tissue implant systems
US6060640A (en) 1995-05-19 2000-05-09 Baxter International Inc. Multiple-layer, formed-in-place immunoisolation membrane structures for implantation of cells in host tissue
WO1996039993A1 (en) * 1995-06-07 1996-12-19 Gore Hybrid Technologies, Inc. An implantable containment apparatus for a therapeutical device and method for loading and reloading the device therein
AU6854696A (en) * 1995-09-22 1997-04-09 Gore Hybrid Technologies, Inc. Improved cell encapsulation device
AU2192997A (en) * 1996-02-28 1997-09-16 Vanderbilt University Compositions and methods of making embryonic stem cells
US5964261A (en) * 1996-05-29 1999-10-12 Baxter International Inc. Implantation assembly
CA2277278A1 (en) 1997-01-10 1998-07-16 Life Technologies, Inc. Embryonic stem cell serum replacement
US6090622A (en) 1997-03-31 2000-07-18 The Johns Hopkins School Of Medicine Human embryonic pluripotent germ cells
US6261281B1 (en) 1997-04-03 2001-07-17 Electrofect As Method for genetic immunization and introduction of molecules into skeletal muscle and immune cells
JP2001516729A (en) 1997-09-15 2001-10-02 ジェネティック・イミューナティ・リミテッド・ライアビリティ・カンパニー Method for delivering genes to antigen-presenting cells of skin
US6074884A (en) * 1997-10-09 2000-06-13 Coulter International Corp. Stable protein-nickel particles and methods of production and use thereof
US5945293A (en) * 1997-10-09 1999-08-31 Coulter International Corp. Protein-colloidal metal-aminodextran coated particle and methods of preparation and use
AU729377B2 (en) * 1997-10-23 2001-02-01 Asterias Biotherapeutics, Inc. Methods and materials for the growth of primate-derived primordial stem cells in feeder-free culture
EP1068295A4 (en) 1998-04-09 2002-08-21 Bresagen Ltd Cell differentiation/proliferation and maintenance factor and uses thereof
US6921811B2 (en) 1998-09-22 2005-07-26 Biosurface Engineering Technologies, Inc. Bioactive coating composition and methods
US6667176B1 (en) 2000-01-11 2003-12-23 Geron Corporation cDNA libraries reflecting gene expression during growth and differentiation of human pluripotent stem cells
DE19852800C1 (en) 1998-11-16 2000-04-13 Univ Albert Ludwigs Freiburg Production of antibodies to a polypeptide encoded by a known DNA sequence comprises binding of antibodies produced by DNA vaccination to immobilized recombinantly expressed polypeptide
CA2355675C (en) * 1998-12-15 2006-07-04 Universidad Nacional Autonoma De Mexico Process and device for facilitating the implantation of biological material
JP2002538779A (en) * 1999-02-10 2002-11-19 キュリス インコーポレイテッド Pancreatic cell progenitor cells, methods and uses related thereto
US6365385B1 (en) * 1999-03-22 2002-04-02 Duke University Methods of culturing and encapsulating pancreatic islet cells
US6872389B1 (en) 1999-07-08 2005-03-29 Rhode Island Hospital Liver stem cell
US6520997B1 (en) 1999-12-08 2003-02-18 Baxter International Inc. Porous three dimensional structure
US6617151B1 (en) * 2000-02-29 2003-09-09 Gore Enterprise Holdings, Inc. Method of closing a cell containment device with a wet seal
US7005252B1 (en) * 2000-03-09 2006-02-28 Wisconsin Alumni Research Foundation Serum free cultivation of primate embryonic stem cells
US6436704B1 (en) * 2000-04-10 2002-08-20 Raven Biotechnologies, Inc. Human pancreatic epithelial progenitor cells and methods of isolation and use thereof
US7256042B2 (en) 2000-04-27 2007-08-14 Geron Corporation Process for making hepatocytes from pluripotent stem cells
US6458589B1 (en) 2000-04-27 2002-10-01 Geron Corporation Hepatocyte lineage cells derived from pluripotent stem cells
CA2417356A1 (en) 2000-08-01 2002-02-07 Yissum Research Development Company Directed differentiation of embryonic cells
AU2002226075A1 (en) 2000-10-23 2002-05-06 University Of Kansas Cadherin peptides for drug delivery and inhibition of tumor metastasis/invasion
US20020090388A1 (en) * 2000-12-01 2002-07-11 Humes H. David Intravascular drug delivery device and use therefor
US6616912B2 (en) 2001-01-05 2003-09-09 Spectrum Laboratories, Inc. Bi-component microporous hollow fiber membrane structure for in vivo propagation of cells
CA2435826A1 (en) 2001-01-24 2002-08-01 The Government Of The United States Of America Differentiation of stem cells to pancreatic endocrine cells
CA2450720A1 (en) 2001-06-13 2002-12-19 Massachusetts Institute Of Technology In vivo bioreactors
US6702857B2 (en) * 2001-07-27 2004-03-09 Dexcom, Inc. Membrane for use with implantable devices
WO2003014313A2 (en) 2001-08-06 2003-02-20 Bresagen, Ltd. Alternative compositions and methods for the culture of stem cells
JP2005501602A (en) * 2001-08-29 2005-01-20 カルバーリョ、リカルド エイ．ピー． デ Sealable implantable device for unidirectional delivery of therapeutic agents to tissue
EP1298201A1 (en) 2001-09-27 2003-04-02 Cardion AG Process for the production of cells exhibiting an islet-beta-cell-like state
US7157278B2 (en) 2001-12-04 2007-01-02 Organogenesis, Inc. Cultured cells from pancreatic islets
ATE532854T1 (en) * 2001-12-04 2011-11-15 Organogenesis Inc CULTIVATED CELLS FROM THE ISLANDS OF LANGERHANS
CA2470539C (en) 2001-12-07 2011-10-04 Geron Corporation Islet cells from human embryonic stem cells
US20030138949A1 (en) 2001-12-12 2003-07-24 Anil Bhushan Methods for the regeneration of pancreatic islets and expansion of pancreatic endocrine cells
US7101546B2 (en) * 2001-12-21 2006-09-05 Amcyte, Inc. In situ maturation of cultured pancreatic stem cells having a specified, intermediate stage of development
US20060003446A1 (en) * 2002-05-17 2006-01-05 Gordon Keller Mesoderm and definitive endoderm cell populations
WO2004098490A2 (en) 2002-05-17 2004-11-18 Mount Sinai School Of Medicine Of New York University Mesoderm and definitive endoderm cell populations
WO2003102134A2 (en) 2002-05-28 2003-12-11 Becton, Dickinson And Company Pancreatic acinar cells into insulin producing cells
CN1668324A (en) 2002-05-28 2005-09-14 诺沃塞尔公司 Methods, compositions and growth and differentiation factors for insulin-producing cells
RU2340330C2 (en) 2002-10-11 2008-12-10 НОВОСЕЛЛ, Инк Implantation of bagged biological materials for treatment of diseases
US20060040385A1 (en) 2002-12-05 2006-02-23 Technion Research & Development Foundation Ltd. Cultured human pancreatic islets, and uses thereof
GB2414480B (en) 2003-02-07 2007-06-27 Wisconsin Alumni Res Found Directed genetic modifications of human stem cells
US20070154981A1 (en) 2003-02-14 2007-07-05 The Board Of Trustees Of The Leland Stanford Junior University Insulin-producing cells derived from stem cells
US20030224411A1 (en) 2003-03-13 2003-12-04 Stanton Lawrence W. Genes that are up- or down-regulated during differentiation of human embryonic stem cells
US20040229350A1 (en) 2003-05-12 2004-11-18 Nikolai Strelchenko Morula derived embryonic stem cells
WO2004104184A1 (en) 2003-05-20 2004-12-02 Riken Preparation of endodermal stem cells
WO2005017131A2 (en) 2003-08-14 2005-02-24 THE GOUVERNMENT OF THE UNITED STATES OF AMERICA as represented by THE SECRETARY OF THE DEPARTMENT F HEALTH AND HUMAN SERVICES Methods for the differentiation of human stem cells
CA2536067A1 (en) 2003-08-27 2005-03-10 Stemcells California, Inc. Enriched pancreatic stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for these populations
WO2005033294A2 (en) 2003-09-30 2005-04-14 Regents Of The University Of California Methods for maintaining hepatocytes in culture and for differentiating embryonic stem cells along a hepatocyte lineage
WO2005059095A2 (en) * 2003-12-10 2005-06-30 The General Hospital Corporation Expansion and differentiation of islet progenitor cells
US20050266554A1 (en) * 2004-04-27 2005-12-01 D Amour Kevin A PDX1 expressing endoderm
US7541185B2 (en) * 2003-12-23 2009-06-02 Cythera, Inc. Methods for identifying factors for differentiating definitive endoderm
US7985585B2 (en) 2004-07-09 2011-07-26 Viacyte, Inc. Preprimitive streak and mesendoderm cells
US7625753B2 (en) * 2003-12-23 2009-12-01 Cythera, Inc. Expansion of definitive endoderm cells
WO2007059007A2 (en) 2005-11-14 2007-05-24 Cythera, Inc. Markers of definitive endoderm
CN103898047B (en) * 2003-12-23 2020-03-03 维亚希特公司 Definitive endoderm
US20050191282A1 (en) * 2004-03-01 2005-09-01 Opara Emmanuel C. Method of cryopreserving pancreatic islet cells
CA2581424A1 (en) * 2004-03-09 2005-09-22 Gang Xu Methods for generating insulin-producing cells
WO2005097980A2 (en) 2004-03-26 2005-10-20 Geron Corporation New protocols for making hepatocytes from embryonic stem cells
CA2555571C (en) 2004-04-01 2012-10-16 Wisconsin Alumni Research Foundation Differentiation of stem cells to endoderm and pancreatic lineage
CA2564114C (en) 2004-04-27 2018-10-09 Cythera, Inc. Pdx1 expressing endoderm
CN100457900C (en) * 2004-06-29 2009-02-04 天津大学 Metal microcapsule for transplanting cell and tissue
CA2573283C (en) 2004-07-09 2023-03-14 Cythera, Inc. Methods for identifying factors for differentiating definitive endoderm
NZ582597A (en) 2004-07-09 2011-08-26 Viacyte Inc Preprimitive streak and mesendoderm cells
EP1791952A4 (en) 2004-08-13 2008-06-11 Univ Georgia Res Found COMPOSITIONS AND METHODS FOR SELF-RENEWAL AND DIFFERENTIATION IN HUMAN EMBRYONIC STEM CELLS
US20060063141A1 (en) * 2004-09-17 2006-03-23 Mcgann Locksley E Method of cryopreserving cells
EP1797171A1 (en) 2004-09-29 2007-06-20 Cellartis AB Methods for the generation of hepatocyte-like cells from human blastocyst-derived stem (hbs)
CA2596231A1 (en) * 2005-01-28 2006-08-03 Novathera Ltd Methods for embryonic stem cell culture
JP2008528038A (en) 2005-01-31 2008-07-31 エス セル インターナショナル ピーティーイー リミテッド Directed differentiation of embryonic stem cells and their use
US20060182722A1 (en) * 2005-02-11 2006-08-17 Hering Bernhard J Methods and materials for isolating isogenic islet cells
CN100425694C (en) 2005-04-15 2008-10-15 北京大学 Method of inducing embryo stem cell to differentiate toward pancreatic cell
WO2007002210A2 (en) 2005-06-20 2007-01-04 Bresagen, Inc. Embryonic stem cell culture compositions and methods of use thereof
AU2006305879B2 (en) * 2005-10-27 2012-05-10 Viacyte, Inc. PDX1-expressing dorsal and ventral foregut endoderm
GB0522564D0 (en) * 2005-11-04 2005-12-14 Reneuron Ltd Cells
GB0602063D0 (en) 2006-02-02 2006-03-15 Univ Manchester Cell Culture
US7850983B2 (en) 2006-02-07 2010-12-14 Spinalcyte, Llc Methods and compositions for repair of cartilage using an in vivo bioreactor
KR20080109775A (en) * 2006-02-23 2008-12-17 노보셀, 인크 Compositions and methods useful for culturing differentiable cells
US7695965B2 (en) * 2006-03-02 2010-04-13 Cythera, Inc. Methods of producing pancreatic hormones
EP1999253B1 (en) * 2006-03-02 2019-05-22 Viacyte, Inc. Endocrine precursor cells, pancreatic hormone-expressing cells and methods of production
EP2422802A3 (en) * 2006-03-07 2013-03-06 Geeta Shroff Compositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation
US20070237749A1 (en) * 2006-04-07 2007-10-11 Wang Taylor G Multi-membrane immunoisolation system for cellular transplant
US8741643B2 (en) * 2006-04-28 2014-06-03 Lifescan, Inc. Differentiation of pluripotent stem cells to definitive endoderm lineage
AU2007277364B2 (en) 2006-07-26 2010-08-12 Viacyte, Inc. Methods of producing pancreatic hormones
WO2008052046A2 (en) * 2006-10-24 2008-05-02 Case Western Reserve University Compositions for coating cell membranes and methods of use thereof
US20080241250A1 (en) 2006-11-08 2008-10-02 Emans Pieter J In vivo bioreactors and methods of making and using same
AU2007332869B2 (en) * 2006-12-07 2012-10-11 Wilson Wolf Manufacturing, LLC Highly efficient gas permeable devices and methods for culturing cells
US20080279833A1 (en) 2007-05-10 2008-11-13 Matheny Robert G Laminate sheet articles for tissue regeneration
US7695963B2 (en) * 2007-09-24 2010-04-13 Cythera, Inc. Methods for increasing definitive endoderm production
US8623650B2 (en) * 2007-10-19 2014-01-07 Viacyte, Inc. Methods and compositions for feeder-free pluripotent stem cell media containing human serum
WO2009059072A2 (en) 2007-10-30 2009-05-07 Tufts University Analysis of endogenous fluorescence images to extract morphological/organization information about living samples
US8338170B2 (en) * 2008-04-21 2012-12-25 Viacyte, Inc. Methods for purifying endoderm and pancreatic endoderm cells derived from human embryonic stem cells
US8008075B2 (en) * 2008-11-04 2011-08-30 Viacyte, Inc. Stem cell aggregate suspension compositions and methods of differentiation thereof
AU2009313870B2 (en) 2008-11-14 2013-07-11 Viacyte, Inc. Encapsulation of pancreatic cells derived from human pluripotent stem cells
EA025142B1 (en) 2009-08-28 2016-11-30 Сернова Корпорэйнш Method and device for cellular transplantation
SG181687A1 (en) 2009-12-23 2012-07-30 Centocor Ortho Biotech Inc Differentiation of human embryonic stem cells
RU2663339C1 (en) 2010-05-12 2018-08-03 Янссен Байотек, Инк. Differentiation of human embryo stem cells
US10702008B2 (en) 2018-02-26 2020-07-07 Hbn Shoe, Llc Device and method of constructing shoes
US11586805B2 (en) 2021-07-26 2023-02-21 Atlassian Pty Ltd. Machine-learning-based natural language processing techniques for low-latency document summarization

Also Published As

Publication number Publication date
WO2010057039A3 (en) 2010-12-02
EP2356227A2 (en) 2011-08-17
JP2018188484A (en) 2018-11-29
EP2356227B1 (en) 2018-03-28
JP2022125204A (en) 2022-08-26
EP4176888A1 (en) 2023-05-10
CN102282254B (en) 2015-12-16
ES2932850T3 (en) 2023-01-27
US20110280915A1 (en) 2011-11-17
JP2012508584A (en) 2012-04-12
US20130209425A1 (en) 2013-08-15
JP2014159477A (en) 2014-09-04
US8425928B2 (en) 2013-04-23
CA2743641A1 (en) 2010-05-20
EP2356227A4 (en) 2013-08-21
AU2009313870A1 (en) 2011-06-30
EP3363444B1 (en) 2022-09-14
US20130261568A1 (en) 2013-10-03
US20160067380A1 (en) 2016-03-10
WO2010057039A2 (en) 2010-05-20
US9913930B2 (en) 2018-03-13
CN102282254A (en) 2011-12-14
US20100124564A1 (en) 2010-05-20
JP2017197578A (en) 2017-11-02
ES2667493T3 (en) 2018-05-11
US8278106B2 (en) 2012-10-02
CA3229301A1 (en) 2010-05-20
AU2009313870B2 (en) 2013-07-11
AU2009313870A2 (en) 2011-06-30
US20190201582A1 (en) 2019-07-04
US9764062B2 (en) 2017-09-19
US10272179B2 (en) 2019-04-30
CN105349517B (en) 2021-05-04
CA2743641C (en) 2024-03-26
US20230256137A1 (en) 2023-08-17
US20160038640A1 (en) 2016-02-11
US20170354760A1 (en) 2017-12-14
US11660377B2 (en) 2023-05-30
CN105349517A (en) 2016-02-24
JP2021004258A (en) 2021-01-14
EP3363444A1 (en) 2018-08-22
US9132226B2 (en) 2015-09-15

Similar Documents

Publication Publication Date Title
PL2356227T3 (en) CAPSULATION OF Pancreas CELLS ORIGINATING FROM HUMAN PLURIPOTENTIAL STEM CELLS
BR112012001564A2 (en) Differentiation of human embryonic stem cells.
BR112012001557A2 (en) differentiation of human embryonic stem cells.
EP3680323C0 (en) PLURIPOTENT STEM CELL ISOLATED FROM BODY TISSUE
EP2346734A4 (en) AILETTE ACTIVE
SE0950586L (en) Improved culture of stem cells
BRPI0814894A2 (en) DIFFERENTIATION OF HUMAN EMBRYONIC STEM CELLS.
DK3130923T3 (en) Therapeutic methods of cancer stem cells
SMT201600040B (en) NON-COVALENT PEPTIDE-MEDIATED RELEASE OF ACTIVE AGENTS THROUGH THE EMATHYRAL-BARRIER BARRIER
BRPI0814425A2 (en) DIFFERENTIATION OF HUMAN EMBRYONIC STEM CELLS
BR112012001480A2 (en) Differentiation of human embryonic stem cells
FR2947716B1 (en) IMPLANT IMPLANT IMPROVED
EP2556145A4 (en) ANGIOGENESIS EMPLOYING PLACENTARIAN STEM CELLS
EP2467097A4 (en) POROUS IMPLANT STRUCTURES
EP2315829A4 (en) INDUCED PLURIPOTENT STEM CELLS
PL2611909T3 (en) DIVERSITY OF HUMAN EMBRIONAL STEM CELLS
PL3050571T3 (en) Digestive enzyme preparation for the treatment of eclampsia
BRPI0822221A2 (en) Aqueous and stable cyclosporine compositions
BRPI0913925A2 (en) Differentiation of pluripotent stem cells
GB0814249D0 (en) Uses of mesenchymal stem cells
DOP2011000397A (en) NEW DERIVATIVES OF PHENYLIMIDAZOL AS INHIBITORS OF THE ENZYME PDE10A
IT1396692B1 (en) STRUCTURE OF PROSTHESES FOR AMPUTES TO THE LOWER LIMBS.
DK3591046T3 (en) AMYLASE POLYPEPTIDE
EP2643012A4 (en) PROTEIN ADMINISTRATION FROM STEM CELL MICROVECTORS
SMT201600332B (en) COMPOSITIONS AND METHODS FOR THE INCREASE OF THE TELOMERASICA ACTIVITY